Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-16
2007-10-16
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S124000, C544S131000
Reexamination Certificate
active
10478153
ABSTRACT:
The present invention relates to compounds of formula (I):or pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, use as Raf Kinase Inhibitors and treatment methods for neurotraumatic diseases and cancer.
REFERENCES:
patent: 3707475 (1972-12-01), Lombardino
patent: 3940486 (1976-02-01), Fitzi
patent: 4348404 (1982-09-01), Whitney
patent: 4447431 (1984-05-01), Sallmann
patent: 4735958 (1988-04-01), Roth et al.
patent: 5166214 (1992-11-01), Billheimer et al.
patent: 5179117 (1993-01-01), Maduckuie, Jr.
patent: 5227486 (1993-07-01), Merce-Vidal et al.
patent: 5236917 (1993-08-01), Dunlap et al.
patent: 5302610 (1994-04-01), Manning et al.
patent: 5310748 (1994-05-01), Wilde et al.
patent: 5514505 (1996-05-01), Limburg et al.
patent: 5552557 (1996-09-01), Fujii et al.
patent: 5593991 (1997-01-01), Adams et al.
patent: 5620999 (1997-04-01), Weier et al.
patent: 5656644 (1997-08-01), Adams et al.
patent: 5665753 (1997-09-01), Frazee et al.
patent: 5717100 (1998-02-01), Selnick et al.
patent: 5733882 (1998-03-01), Carr et al.
patent: 5776954 (1998-07-01), deLaszlo et al.
patent: 5792778 (1998-08-01), deLaszlo et al.
patent: 5837719 (1998-11-01), deLaszlo et al.
patent: 5859041 (1999-01-01), Liverton et al.
patent: 5861420 (1999-01-01), Reitz et al.
patent: 5880139 (1999-03-01), Chang
patent: 5932576 (1999-08-01), Anantanarayan et al.
patent: 5939421 (1999-08-01), Palanki et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 5965583 (1999-10-01), Beers et al.
patent: 6008235 (1999-12-01), Adams et al.
patent: 6040320 (2000-03-01), Beers et al.
patent: 6087381 (2000-07-01), Hanson et al.
patent: 6096753 (2000-08-01), Spohr et al.
patent: 6136828 (2000-10-01), Elliott
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6150372 (2000-11-01), Palanki et al.
patent: 6180643 (2001-01-01), Zablocki et al.
patent: 6207687 (2001-03-01), Claiborne et al.
patent: 6214830 (2001-04-01), Beers et al.
patent: 6235760 (2001-05-01), Feuerstein
patent: 6316464 (2001-11-01), Cheng et al.
patent: 6335336 (2002-01-01), Anantanarayan et al.
patent: 6342510 (2002-01-01), Isakson et al.
patent: 6423713 (2002-07-01), Anantanarayan et al.
patent: 6436966 (2002-08-01), Ohkawa et al.
patent: 6440973 (2002-08-01), Zablocki et al.
patent: 6479507 (2002-11-01), Cheng et al.
patent: 6503930 (2003-01-01), Hanson et al.
patent: 6514977 (2003-02-01), Anantanarayan et al.
patent: 6521655 (2003-02-01), Beers et al.
patent: 6525059 (2003-02-01), Anantanarayan et al.
patent: 6545009 (2003-04-01), Sugiyama et al.
patent: 6548520 (2003-04-01), Adams et al.
patent: 6579873 (2003-06-01), Anantanarayan et al.
patent: 6602877 (2003-08-01), Banborough et al.
patent: 6605634 (2003-08-01), Zablocki et al.
patent: 6608060 (2003-08-01), Bemis et al.
patent: 6617324 (2003-09-01), Naraian et al.
patent: 6649604 (2003-11-01), Spohr et al.
patent: 6852740 (2005-02-01), Hanson et al.
patent: 6979686 (2005-12-01), Naraian et al.
patent: 6987119 (2006-01-01), Gaiba et al.
patent: 7019005 (2006-03-01), Naraian et al.
patent: 7071198 (2006-07-01), Naraian et al.
patent: 7153959 (2006-12-01), Naraian et al.
patent: 2001/0044538 (2001-11-01), Cheng et al.
patent: 2002/0013354 (2002-01-01), Cheng et al.
patent: 2002/0086869 (2002-07-01), Anantanarayan et al.
patent: 2003/0096819 (2003-05-01), Zablocki et al.
patent: 2003/0134837 (2003-07-01), Gaiba et al.
patent: 2003/0139462 (2003-07-01), Cheng et al.
patent: 2003/0144529 (2003-07-01), Hanson et al.
patent: 2003/0153588 (2003-08-01), Steadman et al.
patent: 2004/0038964 (2004-02-01), Dean et al.
patent: 2004/0053943 (2004-03-01), Adams et al.
patent: 2004/0106668 (2004-06-01), Gregory et al.
patent: 2004/0127496 (2004-07-01), Dean et al.
patent: 2004/0147579 (2004-07-01), Naraian et al.
patent: 2004/0176433 (2004-09-01), Naraian et al.
patent: 2004/0192689 (2004-09-01), Dean et al.
patent: 2004/0198730 (2004-10-01), Dean et al.
patent: 2004/0209883 (2004-10-01), Bamford et al.
patent: 2004/0235843 (2004-11-01), Bamford et al.
patent: 2004/0248896 (2004-12-01), Dean et al.
patent: 2004/0254186 (2004-12-01), Dean et al.
patent: 2005/0009844 (2005-01-01), Bemis et al.
patent: 2005/0043355 (2005-02-01), Gregory et al.
patent: 2006/0235014 (2006-10-01), Bemis et al.
patent: 3935514 (1991-05-01), None
patent: 0044486 (1982-01-01), None
patent: 0653421 (1995-05-01), None
patent: 2 306 108 (1997-04-01), None
patent: 2 306 108 (1997-04-01), None
patent: 112 46 437 (1999-09-01), None
patent: WO91/18885 (1991-12-01), None
patent: WO93/23381 (1993-11-01), None
patent: WO95/03297 (1995-02-01), None
patent: WO96/03387 (1996-02-01), None
patent: WO96/41645 (1996-12-01), None
patent: WO97/05878 (1997-02-01), None
patent: WO97/12876 (1997-04-01), None
patent: WO 97/12876 (1997-04-01), None
patent: WO97/16441 (1997-05-01), None
patent: WO97/16442 (1997-05-01), None
patent: WO97/24119 (1997-07-01), None
patent: WO97/35855 (1997-10-01), None
patent: WO97/36587 (1997-10-01), None
patent: WO97/47618 (1997-12-01), None
patent: WO97/48672 (1997-12-01), None
patent: WO98/13278 (1998-04-01), None
patent: WO98/16227 (1998-04-01), None
patent: WO98/18788 (1998-05-01), None
patent: WO98/47899 (1998-10-01), None
patent: WO98/52558 (1998-11-01), None
patent: WO98/56788 (1998-12-01), None
patent: WO99/01449 (1999-01-01), None
patent: WO99/03837 (1999-01-01), None
patent: WO99/25717 (1999-05-01), None
patent: WO99/32436 (1999-07-01), None
patent: WO99/32455 (1999-07-01), None
patent: WO99/61437 (1999-12-01), None
patent: WO 00/01688 (2000-01-01), None
patent: WO 00/06563 (2000-02-01), None
patent: WO 00/25791 (2000-05-01), None
patent: WO 00/26209 (2000-05-01), None
patent: WO 00/33836 (2000-06-01), None
patent: WO 00/06124 (2000-11-01), None
patent: WO 00/64422 (2000-11-01), None
patent: JP 2001/181187 (2001-03-01), None
patent: WO 01/34149 (2001-05-01), None
patent: WO 01/34150 (2001-05-01), None
patent: WO 01/37835 (2001-05-01), None
patent: WO 01/38324 (2001-05-01), None
patent: WO 01/66539 (2001-09-01), None
patent: WO 01/66540 (2001-09-01), None
patent: WO 01/87877 (2001-11-01), None
patent: WO 02/024680 (2002-03-01), None
patent: WO 02/39954 (2002-05-01), None
patent: WO 02/057255 (2002-07-01), None
patent: WO 02/094808 (2002-11-01), None
patent: WO 03/022832 (2003-03-01), None
patent: WO 03/022836 (2003-03-01), None
patent: WO 03/022837 (2003-03-01), None
patent: WO 03/022838 (2003-03-01), None
patent: WO 03/022840 (2003-03-01), None
patent: WO 03/022883 (2003-03-01), None
U.S. Appl. No. 11/388,058, Adams et al. U.S. Appl. No. 11/388,058 is con. Of U.S. Appl. No. 10/432,092, filed Mar. 23, 2006.
U.S. Appl. No. 11/333,033, Steadman et al. U.S. Appl. No. 11/333,033 is con. Of U.S. Appl. No. 10/220,674, filed Jan. 17, 2006.
Adams et al.,Bioorganic&Medical Chemistry Letters, vol. 8, pp. 3111-3116, (1998).
Adams et al.,Current Opinion in Drug Discovery and Development, vol. 2(2), pp. 96-109, (1999).
Alves, et al.,Tetrahedron Letters, vol. 29, pp. 2135-2136, (1988).
Antolini et al.,Bioorganic&Medical Chemistry Letters, vol. 9, pp. 1023-1028, (1999).
Ashley Publications, “Two Novel structural classes of p38 Kinase inhibitors,”Exp Opin. Ther. Patentsvol. 9(4) pp. 477-480, (1999).
Ashley Publications, “p38 Inhibitors based on the pyridylurea and pyridylacetoamide templates,”Exp Opin. Ther. Patents, vol. 10(7), pp. 1151-1154, (2000).
Astles et al.,J. Med. Chem., vol. 39, pp. 1423-1432, (1996).
Bilodeau et al.,J. Org. Chem., vol. 63, pp. 2800-2801, (1998).
Boehm et al.,Exp Opinion Ther. Patents, vol. 10(1) pp. 25-37, (2000).
Boehm et al.,J. Med Chem., vol. 39, pp. 3929-3937, (1996).
Cascieri et al.,The Journal of Biological Chemistry, vol. 274, No. 13, pp. 8694-8697, Issue of (Mar. 26, 1999).
Claiborne et al.,Tetrahedron Letters, vol. 39, pp. 8939-8942, (1998).
Cohen et al.,Journal of the National Cancer Inst., vol. 95, No. 8, (Apr. 16, 2003).
Cuenda et al.,FEBS Letters, vol. 364, pp. 229-233, (1995).
Davies et al.,Nature, vol. 417, pp. 949-954, (Jun. 27, 2002).
de Laszlo et al.,Bioorganic&Medical Chemistry Letters, vol. 8, pp. 2689-2694, (1998).
de L
Dean David Kenneth
Takle Andrew Kenneth
Wilson David Matthew
Hsu Grace C.
Kinzig Charles M.
McCarthy Mary E.
Morris Patricia L.
SmithKline Beecham P.L.C.
LandOfFree
Imidazole-2-carboxamide derivatives as Raf kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole-2-carboxamide derivatives as Raf kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole-2-carboxamide derivatives as Raf kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3902456